As heap utilization approaches 100% and the inevitable OutOfMemoryError threatens to crash the production JVM, DevOps professionals who tend real-time Java ...

In this Microsoft SQL Server and JDBC tutorial, you'll learn how to connect to a Microsoft SQL Server in Java using JDBC. The steps are relatively straightforward: Each database is different, so ...

JEP 533, Structured Concurrency, has reached integrated status for JDK 27. It refines exception handling and type safety in ...

Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Natalya Yashina is a CPA, DASM with over 12 years of experience in ...

Today's applications require monitoring, logging, configuration, etc. Each of these concerns can be implemented as a ...

The visual system is the part of the central nervous system that is required for visual perception – receiving, processing and interpreting visual information to build a representation of the visual ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Boston College economists Tayfun Sönmez and Utku Ünver have been working to ensure that policy makers have a way to ensure that the coronavirus vaccine is distributed equitably across all population ...

Rachel Williams has been an editor for nearly two decades. She has spent the last five years working on small business content to help entrepreneurs start and grow their businesses. She’s well-versed ...

Document management is an important yet time-consuming process — especially if you’re not using an electronic system to help you. A computerized filing system can assist with creating, storing, ...

The lymphatic system is a network of vessels, nodes, and ducts that pass through almost all bodily tissues. It allows the circulation of a fluid called lymph through the body in a similar way to blood ...

Mar. 2, 2026 Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with custom-engineered immune cells that protect them. The goal is to stop the ...